QYResearch：2022年全球體外膜氧合系統市場規模預計達到2.9億美元

QYR

2022年全球體外膜氧合系統市場規模預計達到2.9億美元

Global Extracorporeal Membrane Oxygenation (ECMO) Systems Market Will Reach 293 Million USD in 2022

最近，QYResearch發表了關於體外膜氧合的報告。ECMO的本質是一種改良的人工心肺機，最核心的部分是膜肺和血泵，分別起人工肺和人工心的作用。ECMO運轉時，血液從靜脈引出，通過膜肺吸收氧，排出二氧化碳。經過氣體交換的血，在泵的推動下可回到靜脈(VV通路)，也可回到動脈(VA通路)。前者主要用於體外呼吸支持，後者因血泵可以代替心臟的泵血功能，既可用於體外呼吸支持，又可用於心臟支持。當患者的肺功能嚴重受損，對常規治療無效時，ECMO可以承擔氣體交換任務，使肺處於休息狀態，為患者的康復獲得寶貴時間。同樣患者的心功能嚴重受損時，血泵可以代替心臟泵血功能，維持血液循環。

Recently, QYResearch published a report on ECMO. Extracorporeal Membrane Oxygenation (ECMO) Systems is a new treatment method aimed at heart and lung failure disease. ECMO transport is an effective method of transferring patients with severe ARDS. It has multiple causes, and the diagnosis should be investigated and treatment commenced during ECMO. Since ECMO is a complicated and high-risk therapy, adequate training in its performance and creation of a referring hospital network are essential.

2016年全球體外膜氧合（ECMO）系統收入市場約為2.47億美元，2012年至2016年的複合年增長率為3.16％。全球體外膜氧合（ECMO）系統銷售量在2016年約為1087個單位，從2012年到2016年的年均複合增長率為4.36％。

The global extracorporeal membrane oxygenation (ECMO) system revenue market is about 247 million USD in 2016, at a developing CAGR of 3.16% from 2012 to 2016. The global extracorporeal membrane oxygenation (ECMO) system sales volume is about 1087 units in 2016, with developing CAGR of 4.36% from 2012 to 2016.

到2022年，全球體外膜氧合（ECMO）系統銷售收入估計將增長到2.9億美元左右，從2016年到2022年的複合年增長率為2.50％。

The global extracorporeal membrane oxygenation (ECMO) system sales revenue is estimated to grow to around 293 million USD by 2022, at a developing CAGR of 2.50% from 2016 to 2022.

全球體外膜氧合（ECMO）系統市場以北美（41.21％）和歐洲（34.34％）為主。由於醫生和患者的病人安全和意識的提高，市場正在逐年增長。亞洲市場發展最快，該種設備在醫院的安裝比例逐漸增加。但是醫生的手術技術還有待提高。

In 2016, the global extracorporeal membrane oxygenation (ECMO) system market is dominated by North America (41.21%) and Europe (34.34%). The market is growing due to improved patient safety and awareness among the doctors and patients. The Asian market is growing due to increasing adoption rate of ECMO machine in hospitals, success rate of ECMO & government initiatives, and growing awareness towards ECMO.

對於中國市場來說，行業發展很快。主要參與者有Medtronic, Maquet, Sorin, Terumo and Xenios。Medtronic和Maquet在2016年享有超過50％的市場份額。

For China market, the industry is developing rapidly. The main players are Medtronic, Maquet, Sorin, Terumo and Xenios. Medtronic and Maquet enjoy more than 50% market share in 2016.

喜歡這篇文章嗎？立刻分享出去讓更多人知道吧！